HURA (TuHURA Biosciences Inc.) Multiplikator EV/Sales

Simbol resmi perusahaan TuHURA Biosciences Inc. (HURA)

TuHURA Biosciences, Inc. (HURA) is valued by oncologists for its cutting-edge developments in anti-tumor vaccines. The business possesses high crisis resilience and remains independent of macroeconomic cycles. Structural flexibility is ensured through the complete outsourcing of production and trials. This EV/Sales chart on GURU.Markets reflects the enterprise value excluding debt, where 0.00 captures the most recent value of the metric.

TuHURA Biosciences, Inc. - Multiplikator EV/Sales HURA (periode 23.11.2025 - 20.11.2026)

tuhurabio.com - rincian analitis lan metrik utama (HURA)

- data saldo dhuwit lan arus kas:
Pambiji fundamental perusahaan:HURA (TuHURA)
Sampel barang TuHURA Biosciences, Inc.

Expectations regarding the final trial stages of TuHURA Biosciences, Inc. (HURA) anti-cancer vaccines are driving current market valuation. This indicator compares the total enterprise value, including net debt, to sales volume. An increase in the EV-to-revenue ratio signals inflated investor expectations in the absence of current cash flow, while a decrease may indicate an undervaluation of future commercial prospects. The EV-to-revenue trend reflects the balance between asset value and actual operational efficiency.

Analisis pesaing

Rasio nilai perusahaan marang dodolan BeiGene Ltd (ONC)|Halozyme Corp (HALO) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Revolution Medicines Inc (RVMD)|Rasio nilai perusahaan marang pendapatan Ascentage Pharma Group|Rasio nilai perusahaan marang pendapatan CGON (CG Oncology Corp)|Rasio nilai perusahaan marang pendapatan UroGen Pharma (URGN)|Multiplikator EV/Sales Bicara Therapeutics (BCAX)|Multiplikator EV/Sales PSNL (personalis.com)|Nilai bisnis marang pendapatan ERAS|DCTH: Nilai perusahaan marang pendapatan|YmAbs - Koefisien nilai perusahaan marang pendapatan|aurabiosciences.com (AURA) - Rasio nilai perusahaan marang pendapatan|Candel Therapeutics Inc. - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Accuray Inc.|Multiplikator nilai perusahaan marang pendapatan SELLAS Life Sciences Group SLS|Multiplikator EV/Sales ACTU|CTOR - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Protara Therapeutics TARA|Fate Therapeutics (FATE) - Multiplikator nilai perusahaan marang pendapatan|WHWK - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan TScan Therapeutics Inc|championsoncology.com (CSBR) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan XBIT|Nilai perusahaan marang pendapatan CVM|Rasio nilai perusahaan marang pendapatan OSTX (OS Therapies Incorporated)|Multiplikator EV/Sales RADX|ARTV: Nilai perusahaan marang volume dodolan|Multiplikator EV/Sales ANL (Adlai Nortye Ltd)|VERU - Nilai perusahaan marang pendapatan|tempesttx.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan XLO (xiliotx.com)|RENB: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Mural Oncology plc|Rasio nilai perusahaan marang pendapatan Kairos Pharma Inc|OKUR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales GDTC|CRIS (Curis) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan apollomicsinc.com APLM|THAR: Rasio nilai perusahaan marang pendapatan|advanbiomed.com - Multiplikator EV/Sales|Nilai bisnis marang pendapatan GNPX (Genprex, Inc)|Calidi Biotherapeutics Inc. (CLDI) - Rasio nilai perusahaan marang pendapatan|Sunshine Biopharma Inc. (SBFM) - Multiplikator EV/Sales|XBIO (Xenetic Bio) - Multiplikator EV/Sales|Salarius Pharmaceuticals Inc (SLRX) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales PPBT|Multiplikator EV/Sales American Oncology Network Inc (AONC)|Multiplikator EV/Sales BGNE (BeiGene Ltd.)|Koefisien nilai perusahaan marang pendapatan CKPT (Checkpoint Therapeutics)|ELEV - Rasio nilai perusahaan marang pendapatan|ICAD (iCAD Inc.) - Rasio nilai perusahaan marang pendapatan|Ikena (IKNA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Notable Labs, Ltd.|Rasio nilai perusahaan marang pendapatan viracta.com|MOR: Nilai bisnis marang pendapatan|Multiplikator EV/Sales NAYA|Ascentage Pharma - Rasio nilai perusahaan marang pendapatan